Companies / IGC Pharma, Inc.

IGC Pharma, Inc.

NYSE: IGCCIK 1326205POTOMAC, MD

Financials · FY2025

Revenue$869.0K
Net income$-4.15M
Total debt$134.0K
Cash$207.0K
Diluted EPS$-0.05
Shares outstanding100.1M

Ownership

100.1M shares outstanding · as of Apr 27, 2026
9.7%Insiders
Ownership
Insiders9.70%9,709,539
Institutions4.55%4,554,175
Public float85.75%85,827,603

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Mukunda RamCEOCEO · Director
5.55%5,559,839
1.54%1,541,251
Grimaldi ClaudiaPFO · Director
1.37%1,372,714
1.23%1,235,735

Institutional holders 30

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 1, 2026Mukunda Ram
CEO
ExerciseCommon Stock$84.0K+323K
+7.47%
4,649,088
4.64% of shares
low
Apr 1, 2026Grimaldi Claudia
Executive
ExerciseCommon Stock$36.0K+138K
+11.22%
1,372,714
1.37% of shares
low
Apr 1, 2026Moran James P
Director
ExerciseCommon Stock$0+50K
+4.22%
1,235,735
1.23% of shares
low
Apr 1, 2026Moran James P
Director
ExerciseCommon Stock$0+80K
+7.23%
1,185,735
1.18% of shares
low
Apr 1, 2026Grimaldi Claudia
Executive
ExerciseCommon Stock$0+100K
+8.82%
1,234,252
1.23% of shares
low
Apr 1, 2026Prins Richard K
Director
ExerciseCommon Stock$0+70K
+4.76%
1,541,251
1.54% of shares
low
Apr 1, 2026Prins Richard K
Director
ExerciseCommon Stock$0+100K
+7.29%
1,471,251
1.47% of shares
low
Apr 1, 2026Mukunda Ram
CEO
ExerciseCommon Stock$0+33K
+3.80%
910,751
0.91% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IGCCommon StockEquity45408X308BBG000NSSLY8